Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| R01CA207513 | Role of KLHL6 inactivation in mature B-cell malignancies | 1 | 2025 |
| R01CA224605 | Dual-pronged nano-drug delivery using plant virus-like particles | 1 | 2025 |
| R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 1 | 2025 |
| R01CA260872 | A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients | 1 | 2025 |
| R01CA268179 | Functional interplay between Hippo and estrogen receptor ESR1 | 1 | 2025 |
| R01CA272487 | A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy | 1 | 2025 |
| R01DC004428 | Characterization and treatment of the scarred vocal fold | 1 | 2025 |
| R01DE018304 | ART Modulation of Viral Pathogenesis | 1 | 2025 |
| R01DE032707 | PKR sensing of mitochondrial dsRNA in childhood Sjogrens disease | 1 | 2025 |
| R01DK098672 | Regulation of Mitochondrial Function by Orphan Protein Phosphatases | 1 | 2025 |
| R01DK117850 | Systems Genetics Dissection of Non-alcoholic Steatohepatitis | 1 | 2025 |
| R01ES026033 | Organic-metal mixtures and neurodevelopment | 1 | 2025 |
| R01ES027778 | Mechanism for arsenic induced carcinogenesis | 1 | 2025 |
| R01ES032786 | Integrative Modeling of Biomolecular Machinery in Nucleotide Excision Repair | 1 | 2025 |
| R01EY028554 | Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | 1 | 2025 |
| R01GM042699 | Biochemistry of Pre-mRNA Splicing | 1 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 1 | 2025 |
| R01GM131641 | Mapping endogenous protein dynamics in living cells | 1 | 2025 |
| R01HD054681 | [RNW] - Gamete Interactions in Caenorhabditis elegans | 1 | 2025 |
| R01HG012216 | Extensive multiplexing of protein nucleic-acid interactions to comprehensively study gene expression regulation from chromatin to mRNA degradation | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=6